Mary BethScholandMD
Pulmonology • Salt Lake City, UTCritical Care Medicine, Pleural Disease
Assistant Professor, Internal Medicine, University of Utah School of Medicine
Are you Dr. Scholand?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 76 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
50 N Medical Dr
Salt Lake City, UT 84132Phone+1 801-581-7806
Summary
- Dr. Mary Beth Scholand, MD is a pulmonologist in Salt Lake City, Utah. She is currently licensed to practice medicine in Utah, Montana, and Wyoming. She is affiliated with University of Utah Health, George E. Wahlen Department of Veterans Affairs Medical Center, and LDS Hospital.
Education & Training
University of Utah HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1998 - 2002
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1990 - 1993- Washington University in St. Louis School of MedicineClass of 1990
Certifications & Licensure
UT State Medical License 2001 - 2026
MT State Medical License 2022 - 2024
ID State Medical License 2020 - 2023
WY State Medical License 2022 - 2023
CO State Medical License 1993 - 2005- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF Start of enrollment: 2009 Oct 01
- Long-term Oxygen Treatment Trial Start of enrollment: 2009 Jan 01
- AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis Start of enrollment: 2009 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF study.Lisa Lancaster, Vincent Cottin, Murali Ramaswamy, Wim A Wuyts, R Gisli Jenkins
Therapeutic Advances in Respiratory Disease. 2024-11-08 - 1 citationsBexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial.Lisa Lancaster, Vincent Cottin, Murali Ramaswamy, Wim A Wuyts, R Gisli Jenkins
American Journal of Respiratory and Critical Care Medicine. 2024-08-15 - 1 citationsDesign of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis.Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, Ivan O Rosas, Mary Beth Scholand
BMC Pulmonary Medicine. 2024-03-20
Press Mentions
Comprehensive COVID-19 ‘Long-Hauler’ Clinic Opens at U of U HealthJune 3rd, 2021- Joint 3i/U2M2 Project Grants Open Pathways for Infectious Disease ResearchApril 29th, 2021
Officials Break Ground on U. Facility Expected to Increase University Hospital's CapacityJune 30th, 2017
